| アイテムタイプ |
学術雑誌掲載論文(1) |
| 公開日 |
2026-02-09 |
| タイトル |
|
|
タイトル |
Recent advances in therapeutic strategies for non-small cell lung cancer |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 著者 |
Po-Lan Su
Naoki Furuya
Alahmadi Asrar
Christian Rolfo
Zihai Li
David P. Carbone
Kai He
|
| キーワード |
|
|
言語 |
en |
|
主題 |
Biomarkers, Non-small-cell lung cancer, NSCLC, Antibody–drug conjugates, Bispecific antibodies, Targeted therapy, Immune checkpoint inhibitors |
| 識別子 |
|
|
識別子 |
https://link.springer.com/article/10.1186/s13045-025-01679-1 |
|
識別子タイプ |
DOI |
| 書誌情報 |
en : Journal of Hematology & Oncology
巻 18,
号 1,
p. 35,
発行日 2025-03-27
|
| 出版者 |
|
|
出版者 |
Springer Nature |
|
言語 |
en |
| 収録物識別子 |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
1756-8722 |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| アクセス権 |
|
|
アクセス権 |
open access |
| 権利情報 |
|
|
権利情報 |
© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
s13045-025-01679-1.pdf (1.6 MB)
.png)
